Skip to main content
lexblog.com/lib/GHNV3M6Pviewrecordjson
LEX-WK-GHNV3M6Pcrawled 2026-03-04 15:56Z

ITC as a Biosimilar Battleground: Genentech Challenges Biocon’s Pertuzumab Biosimilar

Sheena Wang · Jennifer P. Nock · Biosimilars Law Bulletin · Published March 4, 2026

Work details

firm or organization
Rothwell Figg
published
2026-03-04

Citation

Sheena Wang, Jennifer P. Nock, ITC as a Biosimilar Battleground: Genentech Challenges Biocon’s Pertuzumab Biosimilar, Biosimilars Law Bulletin (March 4, 2026) [The Library at LexBlog, LEX-WK-GHNV3M6P, lexpid.org/GHNV3M6P]